Abstract: An Extended Prediction Self-Adaptive Control (EPSAC) strategy is applied to the rocuronium administration, a neuromuscular blocking drug used in anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery. A safe anaesthesia should provide comfort to the patient and best possible working conditions for the surgeon. The muscle relaxant plays an important role and an adequate muscle relaxation, which allows efficient and safe surgery, can be provided using automated control. Moreover, closed-loop control may reduce anesthetist workload and achieve better regulation of muscle relaxation than manual administration, calculating the dose required for each patient and avoiding in this way overdosing. Predictive control requires prior knowledge of system dynamics, therefore a mathematical model is required. A three-compartment model for rocuronium is presented. Several parameter sets are used to simulate different patients and control performance is discussed.
INTRODUCTION
Muscle relaxants are used during surgeries and in intensive care units to facilitate management of ventilation, to control intracranial hypertension, to reduce oxygen consumption, to eliminate shivering, and to provide immobility for certain diagnostic studies. Patients receiving muscle relaxants have critical illness, therefore it is important to select the appropriate drug. The rocuronium properties make it suitable for continuous administration (McCoy et al. 1996) and for target controlled infusions (TCI). The duration of action is similar to that of vecuronium, but it has more rapid onset of action (Foldes et al. 1991) . It is classified as an intermediateduration non-depolarizing neuromuscular blocking agent.
Pharmacological modeling has been used to describe the metabolism of muscle relaxants for more than three decades (Farenc et al. 2001; Wierda et al. 1990; Vermeyen, Hoffman and Saldien 2003) . Compartmental models are formulated on the basis of the minimal number of compartments that adequately fits observed data. This type of model is widely used in different control strategies. Using an automatic control system to maintain skeletal muscle relaxation increases the accuracy of the desired neuromuscular block and minimizes the administered drug at the same time. Furthermore, more appropriate level of relaxation corresponding to the clinical requirement can be targeted as the observation interval is considerably reduced. Closed-loop muscle relaxation control may also play a role in the detection of insufficient level of sedation. Giving a too high dose of muscle relaxant to prevent movement could increase the risk of not detecting insufficient sedation. Closed-loop control avoids complete paralysis, allowing in some cases patient movement to indicate patient responsiveness.
Automatic feedback control of skeletal muscle relaxation has been addressed by several research groups, mainly because syringe pumps can be easily controlled by computer systems and more importantly a direct and reliable measure of effect is available. A variety of control strategies can be found in the literature for muscle relaxants, ranging from on-off, PID controllers (De Vries, Ros & Booij 1986) to model based and adaptive controllers (Kansanaho & Olkkola 1996) . Due to the fact that PID controllers cannot anticipate the response of the patient and do not have any knowledge of the drug metabolism, stability problems are present. Predictive control has some advantages: it is robust against variable and unknown time-delay, over parameterization of system models, and has good disturbance rejection properties. This paper presents an Extended Prediction Self-Adaptive Control (EPSAC) strategy implemented for the administration of rocuronium during general anaesthesia. An overview of the pharmacokinetic and pharmacodynamic patient model is given in the next section. The NEPSAC (Nonlinear EPSAC) approach to MPC is presented in section 3. Simulation results of the closed-loop NEPSAC predictive control strategy when different parameter sets are used to simulate the patients are discussed in section 4. The conclusions are summarized in a final section and future step is suggested.
PATIENT MODEL
The pharmacological modeling comprises two main categories known as pharmacokinetics (PK) and pharmacodynamics (PD). The former category studies the relationship between drug dose and drug concentration existing in the blood plasma, while the latter deals with the effect produced by the drug.
The PK model considered in this paper consists of three compartments. Two peripheral compartments are arranged around a central compartment. After the drug injection, the plasma concentration of rocuronium declines rapidly in exponential phases corresponding to distribution to peripheral compartments and elimination. To identify the drug effect, a 4 th compartment known as the effect compartment has been introduced to the rocuronium kinetics (Fig.1 Regarding the pharmacodynamic (PD) model, an additional hypothetical effect compartment was proposed to represent the lag between drug plasma concentration and drug response. The effect compartment receives drug from the central compartment by a first-order process, but it is assumed that the quantity of drug is so small that it does not affect the pharmacokinetic model. The input to the effect site compartment is expressed by a first-order rate constant, k 1e . The output is also expressed by a first-order rate constant, k e0 . This effect site compartment is represented by the following equation: is the drug concentration in the effect compartment (Sheiner et al. 1979) . The effect compartment is defined as a negligibly small compartment connected to the central compartment. Knowing 0 e k , the apparent concentration in the effect compartment can be calculated since 0 e k will precisely characterize the temporal effects of equilibration between the plasma concentration and the corresponding drug effect.
The level of neuromuscular block can be related to the drug concentration in the effect compartment x e by the following sigmoid equation:
where E(t) is the degree of muscle relaxation, max E denotes the maximum effect achieved by the muscle relaxant, x e,50 is the drug concentration at half maximal effect and represents the patient sensitivity to the drug, and γ determines the steepness of the curve. The following values are taken from (Vermeyen et. al. 2003) : ; 79 . 4 ; 100 ; 100 0
In clinical practice the degree of muscle relaxation or the level of neuromuscular block is measured by assessing responses to peripheral nerve stimulations, typically on the ulnar nerve. The usual method to assess degree of relaxation is based on a train-of-four (TOF) stimulation and the respective measurement of response. To perform a train-offour (TOF) pattern of nerve stimulation, 4 supramaximal electrical stimuli are applied over the course of a 1.5 to 2.0 seconds period (frequency of 2 Hz). Each stimulus causes a muscle contraction, and the "fade" of response to this stimulus is measured. Dividing the level of the fourth response ( 4 r ) by the level of the first response ( 1 r ) provides the TOF ratio: TOF ratio can be analytically calculated using relation (3).
3. CONTROL ALGORITHM EPSAC strategy, as described in detail in , is based on a generic process model:
The signal x(t) is the model output resulting from the model (3) input u(t). The disturbance n(t) includes the effects in the measured output y(t) which do not come from the model input u(t) via the available model. These non-measurable disturbances have a stochastic character with non-zero average value, which can be modelled by a coloured noise process:
with: e(t) -uncorrelated (white) noise with zero mean value; C(q -1 ) and D(q -1 ) -monic polynomials in the backward shift operator q -1 of orders n c and n d . The disturbance filter
is considered to be a design filter (De Keyser & Ionescu 2003) and it plays an important role in MPC.
Prediction Algorithm
The model output x(t) represents the effect of the control input u(t) on the process output y(t) and is also a nonmeasurable signal, and the relationship between u(t) and x(t) is given by the generic dynamic system model:
The fundamental step in MPC methodology consists in prediction of the process output y(t+k) at time instant t,
, over the prediction horizon N 2 , and based on:
-the measurements available at sampling instant t: (7) and by using filtering techniques on the noise model (6) .
Control Algorithm
In EPSAC for linear models, the future response is then considered as being the cumulative result of two effects:
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The two contributions have the following origins:
• effect of past control {u(t-1), 
• effect of future (predicted) disturbances n(t+k|t). The cumulative effect of all impulses and the step is: Using (9) and (10) 
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with the horizons N 1 , N 2 being design parameters, N 1 being equal to the time-delay, in samples. The controller output is then the result of minimizing the cost function:
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where r(t+k/t) is the desired reference trajectory:
with w the setpoint and α a tuning parameter (0 ≤ α ≤ 1) which specifies the desired closed-loop speed. The cost function (13) is a quadratic form in U, having the following structure using the matrix notation from (12) and with R defined similarly to Y:
(15) which leads after minimization w.r.t. U to the optimal solution:
The matrix G T G which has to be inverted has dimension N u x N u . For the default case N u =1, this results in a simple scalar control law. Only the first element ) / ( t t u δ in U * is required in order to compute the actual control input applied to the process:
At the next sampling instant t+1, the whole procedure is repeated taking into account the new measurement information y(t+1). This is called the principle of receding horizon control, another well-known MPC-concept. Equation (15) can be re-written as a quadratic form in U as:
where:
Minimization of ( )
J U results in the solution:
which is equivalent to (16). It is worthwhile to notice that optimization with input constraints (on the manipulated variable) are accepted only if the control horizon N u >1. Since in this study the control horizon is unitary, the input is constrained using clipping .
Nonlinear EPSAC
The concept of base and optimizing controls/responses as introduced in formula (9) is theoretically only valid for linear systems, as it is based on the superposition principle. However, for nonlinear systems, by selecting the base control u base (t+k/t) appropriately, the 2 nd term in (9) can gradually be made equal to zero in an iterative way. This then results in the optimal solution, also for nonlinear systems, because the superposition principle is no longer involved. The procedure can be summarized as follows. At each sampling instant:
; in the case of linear models, the choice is irrelevant for the solution, some simple examples being 0 ) / (
(the last one corresponds to the GPC approach). However, for nonlinear models, it is the objective to obtain finally (in an iterative way) a control policy ) / ( 
, which is the optimal control policy derived at the previous time sample. For a linear model, these are the optimal controls and the procedure can be stopped. For a nonlinear model, these are not the optimal controls because the principle of superposition does not hold, but it is reasonable to assume that the resulting u(./.) are 'closer' to the optimal controls than the previous guess u base (./.); so, for a nonlinear model:
3) continue the procedure -at the same sampling instant! -by taking these { }
and return to step 2).
Continuing this iteration and considering the above mentioned assumption to be true, it can be expected that u base (./.) will converge to the optimal u(./.). Indeed, each time that u base (./.) is closer to u(./.), it means that the δu(./.) are smaller and thus also the term y optimize (./.) in (11) becomes smaller. The superposition principle -used in (11), but in fact invalid for nonlinear systems -is step-by-step 'less involved' (it has less impact). Finally, when the δu(./.) are (practically) zero, the superposition principle is no longer involved and the calculated control signal will thus be optimal, also for the nonlinear system. It is important to realize that in this specific Nonlinear MPC approach, the nonlinear system is never linearized. The nonlinear model is directly used to calculate in every iteration the base responses y base (./.) as well as to calculate the required step/impulse-response coefficients {g i , h i }. These are the only values required in (16) or equivalently, in (19).
RESULTS AND DISCUSSION
Controller performance was evaluated using different parameter sets (Table 1) to simulate the patients. Parameter set 1 was used for the prediction model. The tuning of the NEPSAC parameters was un-changed. It was considered optimal for the following values:
The iteration in the NEPSAC procedure was stopped either when the value of the δu(./.) was 2000 times smaller than the one of the updated u base (./.), or when the number of iterations exceeded 30. It is recommended that the controller updates the drug rate every 10 seconds, therefore a sample time of 10 seconds has been adopted. Fig.3 . shows the time course of muscle relaxation for reference tracking and disturbance rejection. The first scenario represents the ideal case, when there are no modelling errors. Of course this situation never appears in practice, but it helps us get a better view upon the EPSAC performance compared to the situation when it is applied to different patients. In the ideal case the reference is reached in about 6 minutes, while for the worst case scenario the time required is two times higher. The muscle relaxation disturbance associated with an empty infusion bag was considered. Since transport of rocuronium into the patient is stopped, this disturbance is independent of the controller. When the infusion is restarted, a bolus of rocuronium is quickly administered to the patient, resulting in a transient decrease in muscle relaxation around minute 45.
The respective control effort required to produce the above discussed performance is depicted in Fig 4. Since each patient has a different sensitivity to the drug, for the same reference value, the controller sends different drug rates. The patient simulated with the 3 rd set of parameters has a higher sensitivity to rocuronium, therefore less drug is required. The effect of the disturbance caused by the empty infusion bag is lower in this case. Although the controller presented is non-adaptive, it performs sufficiently well in this first stage, on several simulated patients. Further investigation is required to select the proper prediction model and more robustness tests are necessary before applying this controller in routine clinical conditions.
CONCLUSIONS
This contribution presents EPSAC control strategy applied to the administration of rocuronium in general anaesthesia. An overview of a PK-PD model is given and several parameter sets are used to simulate different patients. Performance assessment shows good results in set-point tracking and disturbance rejection. The controller proved insensitivity to inter-patient variability and disturbance represented by an unnoticed empty infusion bag that can occur in clinical conditions. The strategy can be easily extended to a multipleinput multiple-output system, taking into account several drugs administered during general anaesthesia.
